Emerging Health Trends: A Look at Where Science Will Take Us (Collection)

Emerging Health Trends: A Look at Where Science Will Take Us (Collection)

by Karl S. Drlica, David S. Perlin, Paul J. H. Schoemaker, Joyce A. Schoemaker
     
 

3 books illuminate the cutting edge medical research that could save your life

 

Right now, science is transforming what we know about preserving and improving human health. These three extraordinary books take you to the cutting edge of emerging science, presenting new findings that might someday save your life. In Antibiotic

Overview

3 books illuminate the cutting edge medical research that could save your life

 

Right now, science is transforming what we know about preserving and improving human health. These three extraordinary books take you to the cutting edge of emerging science, presenting new findings that might someday save your life. In Antibiotic Resistance: Understanding and Responding to an Emerging Crisis, Karl S. Drlica and David S. Perlin presents a thorough and authoritative overview of the growing resistance of pathogenic bacteria to antibiotics, and what this means to our ability to control and treat infectious diseases. The authors answer crucial questions such as: What is resistance? How does it emerge? How do common human activities promote resistance? What can we do about it? How can we strengthen our defenses against resistance, minimize our risks, extend the effectiveness of current antibiotics, and find new ones faster? Next, in Chips, Clones, and Living Beyond 100: How Far Will the Biosciences Take Us?, Paul and Joyce A. Schoemaker tour the remarkable field of biosciences as it stands today, and preview the directions and innovations that are most likely to emerge in the coming years. They offer a clear, non-technical overview of crucial current developments that are likely to have enormous impact, addressing issues ranging from increased human longevity to global warming, bio-warfare to personalized medicine. Along the way, they illuminate each of the exciting technologies and hot-button issues associated with contemporary biotechnology - including stem cells, cloning, probiotics, DNA microarrays, proteomics, gene therapy, and more. Finally, in It Takes a Genome, Greg Gibson posits a revolutionary new hypothesis: our genome is out of equilibrium, both with itself and its environment. Our bodies weren’t designed to subsist on fat and sugary foods; our immune systems aren’t designed for today’s clean, bland environments; our minds aren’t designed to process hard-edged, artificial electronic inputs from dawn ‘til midnight. That, says Gibson, is why so many of us suffer from chronic diseases that barely touched our ancestors. Gibson reveals the stunningly complex ways genes cooperate and interact; illuminates the genetic “mismatches” that lead to cancer, diabetes, inflammatory and infectious diseases, AIDS, depression, and senility; and considers surprising new evidence for genetic variations in human psychology.

 

From world-renowned leaders and experts, including Karl S. Drlica, David S. Perlin, Paul J. H. Schoemaker, Joyce A. Schoemaker, and Greg Gibson

Product Details

ISBN-13:
9780133039573
Publisher:
Pearson Education
Publication date:
02/20/2012
Sold by:
Barnes & Noble
Format:
NOOK Book
Pages:
736
File size:
6 MB

Meet the Author

Karl Drlica, Ph.D. is Principal Investigator at the Public Health Research Institute Center of the UMDNJ-New Jersey Medical School. His laboratory focuses on fluoroquinolone action and resistance with M. tuberculosis and other bacteria, including approaches to slowing the enrichment and amplification of resistant bacterial subpopulations. Dr. David S. Perlin is a Principal Investigator at the Public Health Research Institute (PHRI) of the UMDNJ-New Jersey Medical School. His laboratory explores mechanisms of antifungal drug resistance, rapid detection of bloodstream pathogens in high-risk patients, discovery of novel molecules to combat tuberculosis, and the development of small animal models for respiratory pathogens. Paul Schoemaker is Research Director of the Mack Center for Technological Innovation at the Wharton School. He is founder and chairman of Decision Strategies International, Inc., a consulting and training firm specializing in strategic planning and executive development. He has written over 70 academic and applied papers, and co-author or editor of several books including Wharton On Managing Emerging Technologies, Winning Decisions, and Profiting from Uncertainty. Joyce A. Schoemaker is a biotech consultant and biology course instructor. Greg Gibson is Professor of Genetics at North Carolina State University in Raleigh, and of Integrative Biology at the University of Queensland, Australia. A leader in the new field of genomics, he serves on the editorial boards of PLoS Genetics, Current Biology, and Genetics. With Spencer V. Muse, he co-authored A Primer of Genome Science, one of the field’s leading textbooks.

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >